INTRODUCTION
Peroxisomes β-oxidize a variety of lipophilic carboxylates including straight-chain fatty acids, 2-methyl branched fatty acids such as pristanic acid and the side chain of the bile acid intermediates di-and tri-hydroxycoprostanic acids [1] . The first reaction of peroxisomal β-oxidation, which consists of the desaturation of an acyl-CoA ester to a 2-trans enoyl-CoA, is catalysed by an FAD-dependent acyl-CoA oxidase that donates electrons directly to molecular O # , yielding H # O # [2] . Over recent years it has become clear that peroxisomes contain multiple acyl-CoA oxidases. Three acyl-CoA oxidases have been purified from rat liver and characterized : (1) palmitoyl-CoA oxidase, which oxidizes the CoA esters of straight-chain fatty acids and prostanoids ; (2) pristanoyl-CoA oxidase, which oxidizes the CoA estes of 2-methyl branched fatty acids ; (3) trihydroxycoprostanoyl-CoA oxidase, which oxidizes the CoA esters of the 2-methyl branched side chains of the bile acid precursors di-and tri-hydroxycoprostanic acids and which also has some activity towards 2-methyl branched fatty acids [3] [4] [5] [6] [7] . Palmitoyl-CoA oxidase and pristanoyl-CoA oxidase are expressed in all rat tissues examined thus far [6, 8] , but trihydroxycoprostanoyl-CoA oxidase is expressed only in liver [3, 9] .
From human liver only two acyl-CoA oxidases have been purified and characterized : (1) palmitoyl-CoA oxidase, the substrate spectrum of which resembles that of its rat counterpart ; (2) branched-chain acyl-CoA oxidase, which oxidizes the CoA esters of 2-methyl branched fatty acids and those of the bile acid intermediates di-and tri-hydroxycoprostanic acids [10] [11] [12] . Both enzymes are expressed in liver as well as in extrahepatic tissues.
Abbreviations used : BAC, bacterial artificial chromosome ; dNTPs, deoxyribonucleoside triphosphates ; EST, expressed sequence tag ; FAD, flavin adenine dinucleotide ; FISH, fluorescence in situ hybridization ; 5h-RACE, 5h-rapid amplification of cDNA ends.
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identity with rat pristanoyl-CoA oxidase and harbouring a peroxisomal C-terminal-targeting signal (SKL), was isolated. Bacterial expression of the cDNA resulted in a fusion protein that was cross-reactive with antibodies directed against rat pristanoyl-CoA oxidase and the C-terminal SKL sequence.
Screening of a genomic library with the isolated cDNA as a probe resulted in a genomic clone in which four introns were localized. By means of fluorescence in situ hybridization the gene for human pristanoyl-CoA oxidase was mapped at chromosome position 4p15.3. We conclude that a gene for pristanoyl-CoA oxidase is present in the human genome. The gene appears to be expressed to such a low extent in liver that its mRNA cannot be detected by routine Northern-blot analysis and that its product remains undetected by standard immunoblotting or by enzyme activity measurements. We speculate that the gene may be expressed under special (e.g. certain developmental stages) conditions or in certain specialized tissues not examined thus far.
Molecular cloning of the rat [8, 9, 13] and human acyl-CoA oxidases [14] [15] [16] [17] revealed that, despite its expression in extrahepatic tissues, branched-chain acyl-CoA oxidase [17] is in fact the human homologue of trihydroxycoprostanoyl-CoA oxidase [9] , both enzymes consisting of 681 amino acids and showing 75 % amino acid identity. In contrast, the amino acid identity between human branched-chain acyl-CoA oxidase [17] and rat pristanoyl-CoA oxidase [8] is only 20 %. Enzyme activity measurements, immunoblot analysis with antibodies raised against rat pristanoyl-CoA oxidase [6] and Northern-blot analysis with rat pristanoyl-CoA oxidase probes [8] all indicated that pristanoyl-CoA oxidase is absent from human tissues. However, to our surprise we found in the EMBL databank human expressed sequence tags (ESTs) that are highly homologous (70-80 %) to stretches of bases in the rat pristanoyl-CoA oxidase cDNA sequence. In this paper we present evidence that a pristanoylCoA oxidase gene is, unexpectedly, present in the human and we describe the isolation of a cDNA encoding a protein that shares 75 % amino acid identity with rat pristanoyl-CoA oxidase.
MATERIALS AND METHODS

Materials
Restriction enzymes and Expand2 High Fidelity DNA polymerase were from Boehringer-Mannheim (Heidelberg, Germany). Taq polymerase (5 units\µl) was obtained from Perkin-Elmer (Foster City, CA, U.S.A.). Human liver marathon 5h-rapid amplification of cDNA ends (5h-RACE) ready cDNA was from Clontech (Palo Alto, CA, U.S.A.). The human liver 5h stretch λgt11 cDNA library was purchased from Stratagene (La Jolla, CA, U.S.A.). [α-$#P]dCTP (300 µCi\mmol) was from ICN (Costa Mesa, CA, U.S.A.). Positively charged Nylon membranes (Hybond N + ) were from Amersham Life Science (Amersham, Bucks, U.K.). Oligonucleotides, deoxyribonucleoside triphosphates (dNTPs) and Ready-to-Go labelling mixtures were obtained from Pharmacia Biotech (Uppsala, Sweden). The PinPoint expression system was from Promega (Madison, WI, U.S.A.).
Isolation of enzymes and preparation of antibodies
Purification of rat liver pristanoyl-CoA oxidase and preparation of antibodies were performed as described previously [6] . Antibodies against the C-terminal SKL peroxisome targeting signal [18] , human branched-chain acyl-CoA oxidase [19] and the 52 or 21 kDa subunits of rat palmitoyl-CoA oxidase [6] were obtained as described previously.
Amplification of parts of the human pristanoyl-CoA oxidase gene
PCR on human liver RACE ready cDNA was carried out with a thermocycler (2400 system from Perkin-Elmer) in a reaction volume of 50 µl consisting of 50 ng of cDNA, oligonucleotide hp1 (0n4 µM ; for the designation of oligonucleotides, see Figure  1 ), oligonucleotide hp2 (0n4 µM), 20 mM Tris\HCl, pH 8n3, 50 mM KCl, 2 mM MgCl # , dNTPs (200 µM each) and 2n5 units of Taq polymerase. Amplification was started with 5 min of incubation at 94 mC, followed by 30 cycles of 1 min denaturation at 94 mC, 2 min annealing at 58 mC and 3 min extension at 72 mC. The reaction was completed by 7 min of incubation at 72 mC. PCR fragments were analysed in 1 % (mass\volume) agarose gels.
Cloning of human pristanoyl-CoA oxidase
cDNA clones for human pristanoyl-CoA oxidase were isolated by screening of 1i10' independent clones of a human liver λgt11 cDNA library. Plaques were lifted on Hybond N + membranes according to the protocol of the manufacturer. The hybridization probe was obtained by random-primed labelling of a BamHI fragment from clone PCox38 (see [8] ) with [α-$#P]dCTP by using Ready-to-Go labelling mixtures. Hybridization and washing of the membranes were carried out exactly as described previously [8] . Isolated phage, which were positive after three rounds of screening, were kept in SM buffer [0n1 M NaCl, 10 mM MgSO % , 7 H # O, 50 mM Tris\HCl, pH 7n5, and 0n01 % (mass\volume) gelatin] at 4 mC until further use.
λgt11 phage inserts from positive clones were amplified by PCR. A single plaque was picked from a plate with freshly plated phage by a pipette tip, and transferred to a tube containing 100 µl of SM buffer. A 10 µl portion of this solution was used in a standard PCR mixture of 100 µl containing 2 µM λgt11-specific primers (see Figure 1 ), 2 mM MgCl # , 50 mM KCl, 10 mM Tris\HCl, pH 8n3, dNTPs (2 mM each) and 2n5 units of Taq polymerase. Inserts were amplified by 5 min of incubation at
Figure 1 cDNA and deduced amino acid sequence of human pristanoyl-CoA oxidase
Nucleotides are numbered in the 5h to 3h direction, starting at the start codon. The 5h untranslated region is indicated by negative numbers. The stop codon is marked by ***. The part of the sequence that overlaps with the different ESTs (AC : AA207238, Z44451, Z45527, T78298, F12169, T65260) is underlined. These ESTs were obtained after screening of the EMBL databank by running the FastA option [25] from the Genetics Computer Group (GCG) package at the EMBL node in Brussels, with the rat pristanoyl-CoA cDNA as query sequence. Primers used for subcloning experiments, PCR and sequencing were : 5h-gt11, f-TGGCGACGACTCCTGGAGCCCG ; 3h-gt11, f-CTGGTAATGGTAGCGACCGGCGC ; hphind, CCGGCCGAAGCTTGATGGCATCCACTGTGGAAGGAGG (Hin dIII site underlined) ; 3h-gt11-pAMP, CXACXACXACXAGACCAACTGGTAATGGTAGC (x l uracil) ; 5h-gt11-pAMP, CAXCAXCAXCAXATATCGACGGTTTCCATATG ; oligonucleotide hp1 94 mC (hot start), 30 cycles of 1 min denaturation at 94 mC, 1 min annealing at 54 mC and 2n5 min extension at 72 mC, followed by 7 min at 72 mC. Longer inserts ( 1n8 kB) could only be amplified by transferring the picked plaque directly in the complete PCR mixture and using the Expand High Fidelity DNA polymerase from Boehringer. Amplified inserts were directly sequenced by the dideoxy chain-termination method [20] with vector and rat or human pristanoyl-CoA oxidase-specific FITC-labelled primers (see Figure 1) . Sequencing was carried out with the ALF sequencer and the cycle sequencing kit from Pharmacia. Before sequencing, the PCR fragments were purified with the Wizard DNA clean-up system from Promega. The insert of phage clone HPCox11 was subcloned in the pAMP vector from Gibco-BRL, after amplification with uracil-containing λgt11-specific primers, according to the protocol of the supplier (clone pAMPhp11). This clone was sequenced several times in both directions on the ALF with the Autoread sequencing kit (Pharmacia).
Bacterial expression of human pristanoyl-CoA oxidase
In order to express human pristanoyl-CoA oxidase, a cDNA fragment containing the complete open reading frame of clone HPCox11 was subcloned in the Xa2 expression vector from Promega (PinPoint expression system). The fragment was generated by PCR with a forward primer (hphind, see Figure 1 ) containing an artificial HindIII restriction site just one base in front of the ATG start codon. PCR was carried out in a mixture consisting of 100 ng of pAMPhp11 DNA, 1 µM forward primer hphind (containing a HindIII restriction site), 1 µM M13 reverse primer (pAMP-specific primer), 2n5 mM MgCl # , 10 mM Tris\HCl, pH 8n3, 50 mM KCl, dNTPs (2 mM each) and 2n5 units of Expand High Fidelity DNA polymerase. Amplification was started by 5 min of incubation at 94 mC, followed by 30 cycles of 1 min denaturation at 94 mC, 1 min annealing at 60 mC, 1n5 min extension at 72 mC, and ended by 7 min at 72 mC. After clean up of the PCR fragment with the Wizard DNA clean up system, the fragment was digested with HindIII and KpnI and ligated to the HindIII-Kpn)-digested Xa2 expression vector. Transformants were checked by restriction enzyme analysis and DNA sequencing. Expression and analysis of the biotinylated fusion protein were performed according to the manufacturer's instructions.
SDS/PAGE and Western blotting
Before PAGE, proteins were solubilized in a buffer containing 0n5 % (mass\volume) SDS. Solubilized proteins were then electrophoresed in a normal (Pharmacia Biotech) or mini (Bio-Rad, Richmond, CA, U.S.A.) vertical gel system as described by Laemmli [21] . After electrophoresis the proteins were semi-dry transferred to nitrocellulose (0n45 µm) [22] and briefly visualized by Ponceau S staining [23] .
For immunostaining the membranes were completely destained in 2 mM NaOH and blocked for 1 h with 5 % (mass\volume) milk powder in TBST [150 mM NaCl, 65 mM KCl, 25 mM Tris\HCl, pH 7 and 0n05 % (v\v) Tween 20] . Then the membrane was incubated with the primary rabbit antibody, diluted in 1 % (mass\volume) milk powder in TBST, for another hour. After extensive washing with TBST, the blot was incubated with an anti-rabbit antibody coupled to alkaline phosphatase diluted in 1 % (mass\volume) milk powder in TBST. Finally, the immune complexes were visualized by staining with Nitro Blue Tetrazolium\5-bromo-4-chloro-3-indolyl phosphate.
Screening of a bacterial artificial chromosome (BAC) library and fluorescent in situ hybridization (FISH)
For the genomic assignment of the human pristanoyl-CoA oxidase gene by FISH, a genomic clone (BAC) was isolated which was subsequently used as a probe. High-density filters with a human BAC library (Research Genetics, Huntsville, AL, U.S.A.) were hybridized with a radioactively labelled HindIII-KpnI fragment of cDNA clone HPCox11 (see above) according to standard hybridization methods. One BAC clone, 267H3, was isolated and its identity confirmed by direct cycle sequencing (Thermosequenase Cycle Sequencing kit from Amersham) of the BAC DNA.
After labelling of the BAC probe with FITC-labelled dUTP, FISH was performed on metaphase and prometaphase spreads of normal white blood cells as described previously [24] .
RESULTS AND DISCUSSION
To discover whether human ESTs were available that showed significant homology to the cDNA for rat pristanoyl-CoA oxidase, the EMBL databank was screened with the FastA option [25] from the GCG package at the EMBL node in Brussels. Several highly homologous (around 75 %) cDNA sequences were obtained, which partly overlapped the sequence in question (Figure 1 ). The existence of these ESTs was an indication that, despite the fact that pristanoyl-CoA oxidase cannot be detected in human tissues, a gene for pristanoyl-CoA oxidase might be present in the human.
In order to obtain the complete cDNA derived from a putative gene for human pristanoyl-CoA oxidase, we initially performed PCR on human liver RACE ready cDNA with EST-specific primers. With oligonucleotides hp1 and hp2 (see Figure 1) we were able to amplify a fragment of 500 bp that showed 100 % identity with the EST between these two primers (results not shown). RACE ready cDNA was used since it also allows amplification of regions of unknown sequence in both 5h and 3h direction. PCR with primer hp2 in combination with the 5h anchor primer and primer hp1 in combination with the 3h anchor primer, however, did not result in any fragments. The 5h and 3h parts are probably too long to be amplified efficiently. We therefore decided to screen a human liver λgt11 cDNA library with $#P-labelled cDNA from rat pristanoyl-CoA oxidase.
Of the initially 1i10' clones, ten appeared to be specific after three rounds of screening. cDNA inserts from positive phage clones were amplified by PCR with vector-specific primers. Sequencing of the PCR products, either directly or after subcloning in an appropriate vector, showed that the isolated clones were highly homologous to the rat pristanoyl-CoA oxidase cDNA. One of the clones (HPCox11) contained a complete open reading frame of 2100 bases encoding a protein of 700 amino acids (Figure 1) . Comparison of its amino acid sequence with that of rat pristanoyl-CoA oxidase (Figure 2) showed 75 % amino acid identity, indicating that the enzyme encoded by the isolated cDNA presumably represents the human homologue of rat pristanoyl-CoA oxidase. We therefore, decided to call the protein human pristanoyl-CoA oxidase.
Amino acid identities of human pristanoyl-CoA oxidase with the other human acyl-CoA oxidases, palmitoyl-CoA oxidase and branched-chain acyl-CoA oxidase, are 20 and 22 % respectively. Human pristanoly-CoA oxidase ends with the well-known peroxisomal SKL-terminal targeting sequence, indicating that the enzyme is indeed a peroxisomal protein and that its apparent absence from human tissues cannot be explained by a defective import into the peroxisome. It should be noted that several peroxisomal matrix proteins, including the β-oxidation enzymes, are rapidly degraded in the cytosol when they are not imported into the peroxisome [26] .
The cDNA of human pristanoyl-CoA oxidase did not reveal premature stop codons or large deletions that could result in a truncated (and possibly inactive) enzyme. In order to confirm that the isolated cDNA codes for the whole protein, we expressed the cDNA in bacteria. By means of PCR, with appropriate primers, we generated a DNA fragment containing the complete open reading frame of human pristanoyl-CoA oxidase. After subcloning of this fragment in the PinPoint expression vector (Xa2), the protein was expressed in Escherichia coli. The bacterially expressed fusion protein had the expected size of 80 kDa (70 kDa plus the 13 kDa fusion part ; Figure 3a , lane 2) and cross-reacted with the antibody against rat pristanoyl-CoA oxidase ( Figure 3b , lane 2) but not with those against human branched-chain acyl-CoA oxidase or the 21 and 52 kDa subunits of palmitoyl-CoA oxidase (results not shown). In addition, the fusion protein reacted with an antibody directed against the Cterminal SKL peroxisomal targeting sequence (Figure 3c, lane 2) confirming that the protein did not end prematurely. We also investigated whether the fusion protein was enzymically active. The protein did not show any enzymic activity towards 2-methylpalmitoyl-CoA (results not shown), probably because of incorrect oligomerization [6] .
By means of genomic analysis we obtained further evidence that a gene for pristanoyl-CoA oxidase is present in the human. A genomic clone (BAC 267H3) was isolated by screening of a BAC library with the complete cDNA of human pristanoyl-CoA oxidase as a probe. Sequencing of this clone with several human pristanoyl-CoA oxidase-specific primers revealed the position of four introns (see Figures 1 and 4) . Intron I, situated between cDNA positions 144 and 145, was partially sequenced from both directions (397 bp). The three other introns (II-IV) were localized between cDNA positions 543 and 544, 1300 and 1301 and 1983 and 1984 respectively (see Figures 1 and 4 ). They were sequenced only partially in the 5h direction. All intron\exon junctions conformed to the general splice-site rules. PCR on rat genomic DNA with two rat pristanoyl-CoA oxidase-specific primers (rp13 and rp14, see ref. [8] ) showed that, in the rat pristanoyl-CoA oxidase gene, an intron is situated at the same position as intron I in the human gene (results not shown). The length of the intron is 300 bp. Obviously, the intron\exon organization of the rat and human pristanoyl-CoA oxidase genes is almost identical. as is also seen for the genes for rat and human palmitoyl-CoA oxidase [14] [15] [16] 27] . FISH with BAC 267H3 showed clear signals on both chromosome 4pter-p15 regions in 80 % of the metaphases ( Figure  5 ). Analysis of prometaphase chromosomes refined the assignment to 4p15.3 ( Figure 5, inset) .
The fact that the transcription and translation product of the gene has not been detected in the human remains a puzzle [6, 8, 12] . We repeated several of our earlier immunoblotting experiments [6] , but pristanoyl-CoA oxidase was not detectable in either human liver homogenates or purified human liver peroxisomes (results not shown). Although this is not final proof of the absence of the protein from the human, the data suggest that, if the protein is present, it must be in very small amounts. We also repeated some of the column separations starting from partially purified human acyl-CoA oxidases [12] . Again, the protein remained undetectable (results not shown).
We conclude that a gene for pristanoyl-CoA oxidase is present in the human genome. The gene appears to be expressed to such a low extent, at least in liver, that its mRNA cannot be detected by routine Northern-blot analysis, and that its product remains undetected by standard immunoblotting or by enzyme activity measurements. The human pristanoyl-CoA oxidase cDNA does not display large deletions, frame shifts or premature stop codons that could result in a truncated and possibly inactive enzyme. In addition, the cDNA codes for a functional c-terminal peroxisomal targeting signal so defective import into the peroxisome is highly unlikely as an explanation for the apparent absence of the protein. One must keep in mind, however, that the human branched-chain acyl-CoA oxidase has taken over the function of pristanoyl-CoA oxidase in human tissues. It is therefore questionable whether there is a physiological role for human pristanoyl-CoA oxidase, at least under normal conditions. The possibility remains that the enzyme is expressed only under
Figure 3 Analysis of bacterially expressed human pristanoyl-CoA oxidase
The cDNA encoding human pristanoyl-CoA oxidase was subcloned in the PinPoint expression system (Promega) as described in the Materials and methods section. All three expression vectors (Xa1, Xa2 and Xa3) were used. In vector Xa2 the cDNA was subcloned in the correct reading frame, and in the other two vectors the reading frame was shifted by one base. In lanes 1, 2 and 3 proteins obtained from cells transfected with the Xa1, Xa2 and Xa3 vector respectively were electrophoresed. In lane 4, 100 ng of purified rat pristanoyl-CoA oxidase was loaded. After blotting, immunostaining was performed with a streptavidin-alkaline phosphatase conjugate (a), affinity-purified rat pristanoyl-CoA oxidase antibody (b) and an antibody directed against the SKL tripeptide (c). In lane 4 of (c) one can see that the latter antibody is specific for SKL. Purified rat pristanoyl-CoA oxidase, which has the tripeptide SQL at its C-terminus, showed no cross-reactivity. Numbers on the left indicate molecular mass (in kDa) of the marker proteins.
special circumstances, e.g. at certain developmental stages, or in specialized tissues not examined thus far. This would be supported by the ESTs, which were derived from brain and fetal liver\spleen tissues.
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Figure 4 Partial structure of the human pristanoyl-CoA oxidase gene
A genomic clone, isolated as described in the Materials and methods section, for human pristanoyl-CoA oxidase was sequenced with several fluorescently labelled primers (see legend to Figure  1 ). With primer hp11 (sense) and hp5 (anti-sense) an intron was localized which was partially sequenced (I). Sequencing of the genomic clone with primers hp15, hp11 and hp14 revealed three other intron/exon junctions (II-IV respectively). All intron/exon junctions were flanked by conserved splice-site bases, which are double underlined. The intron sequence is single underlined. The numbers above the sequences indicate the last or first base of the corresponding exon (numbering according to Figure 1 ). 
